Collection of Cerebrospinal Fluid in Healthy Children
|ClinicalTrials.gov Identifier: NCT01698229|
Recruitment Status : Terminated (Study interest shifted)
First Posted : October 2, 2012
Last Update Posted : May 4, 2016
|Condition or disease||Intervention/treatment|
|Late Infantile Neuronal Ceroid Lipofuscinosis Batten Disease||Other: Group 1|
|Study Type :||Observational|
|Actual Enrollment :||32 participants|
|Official Title:||Collection of Cerebrospinal Fluid in Healthy Children|
|Study Start Date :||December 2011|
|Actual Primary Completion Date :||December 2015|
|Actual Study Completion Date :||December 2015|
Study cohort is comprised of healthy children, ages 2yrs - 8yrs, who are already undergoing a lumbar puncture procedure at New York Presbyterian Hospital for clinical or diagnostic purposes.
Other: Group 1
Collecting a small amount of cerebrospinal fluid (5 mL) from healthy children, ages 2 yrs - 8 yrs, who are already undergoing a lumbar puncture procedure at New York Presbyterian Hospital for clinical or diagnostic purposes.
- Cerebrospinal fluid (CSF) [ Time Frame: 1 time point (once) ]The primary study endpoint is the metabolic profiling of 32 samples of cerebrospinal fluid from healthy subjects, in comparison to 32 samples of CSF from children with LINCL, to determine whether there are biomarkers found in the cerebrospinal fluid that are associated with LINCL.
Biospecimen Retention: Samples Without DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01698229
|United States, New York|
|Weill Cornell Medical College / New York Presbyterian Hospital|
|New York, New York, United States, 10065|
|Principal Investigator:||Ronald G Crystal, MD||Weill Medical College of Cornell University|